Dyskinesia:グローバル臨床試験レビューH1, 2013...市場調査レポートについてご紹介

【英文タイトル】Dyskinesia Global Clinical Trials Review, H1, 2013

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 6
Introduction 7
Dyskinesia 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by G7 Nations 17
Clinical Trials in G7 Nations by Trial Status 18
Clinical Trials by E7 Nations 19
Clinical Trials in E7 Nations by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Dyskinesia 24
Subjects Recruited Over a Period of Time 28
Prominent Sponsors 29
Top Companies Participating in Dyskinesia Therapeutics Clinical Trials 31
Prominent Drug Comparison 33
Clinical Trial Profiles 34
Clinical Trial Overview of Top Companies 34
Neurocrine Biosciences, Inc. 34
Clinical Trial Overview of Neurocrine Biosciences, Inc. 34
Ipsen S.A. 35
Clinical Trial Overview of Ipsen S.A. 35
Novartis AG 36
Clinical Trial Overview of Novartis AG 36
Allergan, Inc. 37
Clinical Trial Overview of Allergan, Inc. 37
Merck KGaA 38
Clinical Trial Overview of Merck KGaA 38
Merck & Co., Inc. 39
Clinical Trial Overview of Merck & Co., Inc. 39
Merz Pharma GmbH & Co. KgaA 40
Clinical Trial Overview of Merz Pharma GmbH & Co. KgaA 40
Eisai Co., Ltd. 41
Clinical Trial Overview of Eisai Co., Ltd. 41
UCB S.A. 42
Clinical Trial Overview of UCB S.A. 42
Addex Therapeutics 43
Clinical Trial Overview of Addex Therapeutics 43
Novartis Pharmaceuticals Corporation 44
Clinical Trial Overview of Novartis Pharmaceuticals Corporation 44
Merz Pharmaceuticals, LLC 45
Clinical Trial Overview of Merz Pharmaceuticals, LLC 45
Eisai Inc. 46
Clinical Trial Overview of Eisai Inc. 46
Allergan Limited 47
Clinical Trial Overview of Allergan Limited 47
Merz Pharmaceuticals GmbH 48
Clinical Trial Overview of Merz Pharmaceuticals GmbH 48
AbbVie Inc. 49
Clinical Trial Overview of AbbVie Inc. 49
Veloxis Pharmaceuticals A/S 50
Clinical Trial Overview of Veloxis Pharmaceuticals A/S 50
Avanir Pharmaceuticals, Inc. 51
Clinical Trial Overview of Avanir Pharmaceuticals, Inc. 51
Cleveland Medical Devices, Inc. 52
Clinical Trial Overview of Cleveland Medical Devices, Inc. 52
Teva Pharmaceutical Industries Limited 53
Clinical Trial Overview of Teva Pharmaceutical Industries Limited 53
Clinical Trial Overview of Top Universities / Institutes / Hospitals 54
University of Florida 54
Clinical Trial Overview of University of Florida 54
Oregon Health and Science University 55
Clinical Trial Overview of Oregon Health and Science University 55
University Health Network 56
Clinical Trial Overview of University Health Network 56
Ziv Medical Center 57
Clinical Trial Overview of Ziv Medical Center 57
Taoyuan Mental Hospital 58
Clinical Trial Overview of Taoyuan Mental Hospital 58
The University of Iowa 59
Clinical Trial Overview of The University of Iowa 59
Assistance Publique – Hopitaux de Paris 60
Clinical Trial Overview of Assistance Publique – Hopitaux de Paris 60
Vanderbilt University 61
Clinical Trial Overview of Vanderbilt University 61
Leiden University Medical Center 62
Clinical Trial Overview of Leiden University Medical Center 62
University of Alabama at Birmingham 63
Clinical Trial Overview of University of Alabama at Birmingham 63
Medical University of Vienna 64
Clinical Trial Overview of Medical University of Vienna 64
Rush University Medical Center 65
Clinical Trial Overview of Rush University Medical Center 65
University of Cologne 66
Clinical Trial Overview of University of Cologne 66
Herzog Hospital 67
Clinical Trial Overview of Herzog Hospital 67
Seoul National University Hospital 68
Clinical Trial Overview of Seoul National University Hospital 68
The University of South Florida 69
Clinical Trial Overview of The University of South Florida 69
Beijing Huilongguan Hospital 70
Clinical Trial Overview of Beijing Huilongguan Hospital 70
Academic Medical Centre 71
Clinical Trial Overview of Academic Medical Centre 71
Groupe Hospitalier Pitie-Salpetriere 72
Clinical Trial Overview of Groupe Hospitalier Pitie-Salpetriere 72
University of North Carolina Project 73
Clinical Trial Overview of University of North Carolina Project 73
Five Key Clinical Profiles 74
Appendix 133
Abbreviations 133
Definitions 133
Research Methodology 134
Secondary Research 134
About GlobalData 135
Contact Us 135
Disclaimer 135
Source 136


【レポート販売概要】

■ タイトル:Dyskinesia:グローバル臨床試験レビューH1, 2013
■ 英文:Dyskinesia Global Clinical Trials Review, H1, 2013
■ 発行日:2013年4月22日
■ 調査会社:GlobalData
■ 商品コード:GDATA403160780
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。